PGP and malignant colon neoplasm: However, it was found that ω-3 PUFAs reduced the total membrane- and lipid-raft-associated Pgp and MRP1, increasing the sensitivity to doxorubicin and irinotecan in colon cancer HT9/MDR cells [97].